Literature DB >> 17446116

Dopamine replacement therapy does not restore the ability of Parkinsonian patients to make rapid adjustments in motor strategies according to changing sensorimotor contexts.

E Tunik1, A G Feldman, H Poizner.   

Abstract

The ability of dopamine replacement to restore rapid motor adjustments in Parkinson's disease (PD) was investigated. Medicated and non-medicated patients performed finger-to-nose movements while simultaneously bending the trunk forward, without vision. Trunk motion was blocked unexpectedly, necessitating rapid adjustments in arm trajectories. Patients exhibited irregular hand paths, plateaus in hand velocity, and prolonged movement times, which were significantly greater in perturbed trials. Medication improved kinematics but perturbation-induced disturbances persisted and did not approximate the levels of non-perturbed trials nor those of controls. Dopaminergic replenishment in PD may therefore have limited restorative benefits for rapid context-specific motor control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446116      PMCID: PMC2211273          DOI: 10.1016/j.parkreldis.2007.02.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  43 in total

1.  Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa.

Authors:  B Haslinger; P Erhard; N Kämpfe; H Boecker; E Rummeny; M Schwaiger; B Conrad; A O Ceballos-Baumann
Journal:  Brain       Date:  2001-03       Impact factor: 13.501

2.  The interaction of visual and proprioceptive inputs in pointing to actual and remembered targets in Parkinson's disease.

Authors:  S V Adamovich; M B Berkinblit; W Hening; J Sage; H Poizner
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

3.  How does Parkinson's disease begin? The role of compensatory mechanisms.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Jose L Lanciego; Manuel Rodriguez Diaz
Journal:  Trends Neurosci       Date:  2004-03       Impact factor: 13.837

4.  Comparison of learning-related neuronal activity in the dorsal premotor cortex and striatum.

Authors:  Peter J Brasted; Steven P Wise
Journal:  Eur J Neurosci       Date:  2004-02       Impact factor: 3.386

5.  Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys.

Authors:  Ludovic Escola; Thomas Michelet; Gaelle Douillard; Dominique Guehl; Bernard Bioulac; Pierre Burbaud
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

6.  Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part II, construct and content validity.

Authors:  Maria João Forjaz; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

7.  Pharmacologically modulated fMRI--cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients.

Authors:  C Buhmann; V Glauche; H J Stürenburg; M Oechsner; C Weiller; C Büchel
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

8.  Ratio of inhibited-to-activated pallidal neurons decreases dramatically during passive limb movement in the MPTP-treated monkey.

Authors:  T Boraud; E Bezard; B Bioulac; C E Gross
Journal:  J Neurophysiol       Date:  2000-03       Impact factor: 2.714

9.  The role of shortening reaction in mediating rigidity in Parkinson's disease.

Authors:  Ruiping Xia; W Zev Rymer
Journal:  Exp Brain Res       Date:  2004-05-04       Impact factor: 1.972

10.  Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia.

Authors:  Matthias Maschke; Christopher M Gomez; Paul J Tuite; Jürgen Konczak
Journal:  Brain       Date:  2003-06-23       Impact factor: 13.501

View more
  17 in total

1.  Human basal ganglia and the dynamic control of force during on-line corrections.

Authors:  Scott T Grafton; Eugene Tunik
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

2.  Correlation among joint motions allows classification of Parkinsonian versus normal 3-D reaching.

Authors:  Jacky Chan; Howard Leung; Howard Poizner
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2009-06-02       Impact factor: 3.802

3.  The effect of dopamine replacement therapy on haptic sensitivity in Parkinson's disease.

Authors:  Kuan-yi Li; Kristen Pickett; Igor Nestrasil; Paul Tuite; Jürgen Konczak
Journal:  J Neurol       Date:  2010-07-14       Impact factor: 4.849

4.  Scaling and coordination deficits during dynamic object manipulation in Parkinson's disease.

Authors:  Joseph Snider; Dongpyo Lee; Deborah L Harrington; Howard Poizner
Journal:  J Neurophysiol       Date:  2014-04-23       Impact factor: 2.714

5.  Parkinson's disease patients show impaired corrective grasp control and eye-hand coupling when reaching to grasp virtual objects.

Authors:  J R Lukos; J Snider; M E Hernandez; E Tunik; S Hillyard; H Poizner
Journal:  Neuroscience       Date:  2013-09-19       Impact factor: 3.590

6.  Impaired endogenously evoked automated reaching in Parkinson's disease.

Authors:  Elizabeth B Torres; Kenneth M Heilman; Howard Poizner
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

7.  Impact of Parkinson's disease on proprioceptively based on-line movement control.

Authors:  David Mongeon; Pierre Blanchet; Stéphanie Bergeron; Julie Messier
Journal:  Exp Brain Res       Date:  2015-06-09       Impact factor: 1.972

8.  Finger tapping movements of Parkinson's disease patients automatically rated using nonlinear delay differential equations.

Authors:  C Lainscsek; P Rowat; L Schettino; D Lee; D Song; C Letellier; H Poizner
Journal:  Chaos       Date:  2012-03       Impact factor: 3.642

Review 9.  Delaying mobility disability in people with Parkinson disease using a sensorimotor agility exercise program.

Authors:  Laurie A King; Fay B Horak
Journal:  Phys Ther       Date:  2009-02-19

10.  Coordination deficits during trunk-assisted reach-to-grasp movements in Parkinson's disease.

Authors:  Miya K Rand; Arend W A Van Gemmert; Abul B M I Hossain; George E Stelmach
Journal:  Exp Brain Res       Date:  2013-10-09       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.